Form 4 for BSX Boston Scientific
Accepted 2023-09-12 00:00:00 ET · period of report 2023-09-12 · accession 0001225208-23-008881 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-09-12 | 2023-09-12 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $14.67 | +113.4K | 1.61M | +8% | +$1.66M |
| D | 2023-09-12 | 2023-09-12 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $53.91 | -113.4K | 1.50M | -7% | -$6.11M |
| DM | 2023-09-12 | 2023-09-12 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | -113.4K | 115.4K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-12 | M | A | 57,680 | $13.08 | 1,556,602 | D | — | — | |
| 2 | Common | Common Stock | 2023-09-12 | S | D | 113,355 | $53.91 | 1,498,922 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $53.54 to $54.53, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2023-09-12 | M | A | 55,675 | $16.31 | 1,612,277 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-09-12 | M | D | 55,675 | $0.00 | 278,376 | D | $16.31 · — to 2025-02-23 | 55,675 Common Stock | (F3) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-09-12 | M | D | 57,680 | $0.00 | 115,361 | D | $13.08 · — to 2024-02-24 | 57,680 Common Stock | (F4) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. |